TOC
CHAPTER ONE: EXECUTIVE SUMMARY
- Rising Incidence
- Complications
- Treatment Options and Recent Advances
- Summary Market Forecast
- Scope and Methodology
CHAPTER TWO: INTRODUCTION TO AUTISM AND RELATED DISORDERS
- Epidemiology
- Cost of Managing Autism Disorders
- Types of Autism
- Causes of Autism
- Complications of Autism
- Social Symptoms
- Communication Difficulties
- Repetitive Behaviors
- Sensory Problems
- Mental Retardation
- Seizures
- Fragile X Syndrome
- Tuberous Sclerosis
CHAPTER THREE: PHARMACOLOGICAL TREATMENTS
- Drugs for Behavioral Problems: Antipsychotic Agents
- Drugs for Anxiety and Depression
- Drugs for Seizures
- Drugs for Inattention and Hyperactivity
- Drugs in Clinical Trials
- Anti-Convulsants
- Antidepressants
- Psychostimulants
- Gene Therapy
- NIH Research
CHAPTER FOUR: MARKET FOR AUTISM THERAPEUTICS
CHAPTER FIVE: KEY PLAYERS AND THEIR TECHNOLOGIES
- deCODE genetics Inc.
- IntegraGen
- Protein Therapeutics Inc.
- Psychiatric Genomics Inc.
- Repligen Corp.
- Target Discovery
LIST OF EXHIBITS
- Exhibit 1: Complications Associated with Autism
- Exhibit 2: World Market for Autism Therapeutics by Geographic Segment
- Exhibit 3: Summary of World Market for Autism Therapeutics 2000-2009
- Exhibit 4: Market Share of Autism and Related Condition Therapeutics by
Drug Type
- Exhibit 5: Cost of Autism Treatment in the United States 2004 and 2013
- Exhibit 6: Classification of Drugs Used in Autism Disorders
- Exhibit 7: Clinical Trials of Dopamine Antagonists in Autism
- Exhibit 8: Clinical Trials for 5-HT Antagonists in Treatment of Autism
- Exhibit 9: Clinical Trials of Naltroxone
- Exhibit 10: Selected Centers Engaged in Autism Research
- Exhibit 11: Worldwide Prevalence of Autism
- Exhibit 12: Geographical Distribution of Autistic Population, 2004
- Exhibit 13: Total World Market for Autism Therapeutics 2000-2004, 2009
- Exhibit 14: World Market for Autism Psychotherapy Agents by Major Region
2004-2009
- Exhibit 15: The Market for Psychotherapy Drugs for Treating Autism by Drug
Type 2004-2009
- Exhibit 16: Market Share of Psychotropic Agents in Treating Autism by Type
- Exhibit 17: Status of Selected Autism Therapeutics in Development
- Exhibit 18: Potential U.S. Market for Secretin 2004-2009
| 
View Cart
